Drug Type RNA aptamer |
Synonyms- |
Target |
Action modulators |
Mechanism EphA2 modulators(Ephrin type-A receptor 2 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hematologic Neoplasms | Preclinical | Spain | 01 May 2024 |





